Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria

The aim of this study is to evaluate the effect of the introduction of biosimilars in Bulgaria on the prices and utilization of biologic disease modifying antirheumatic drugs (bDMARD). It is a combined qualitative and quantitative analysis of time of entry of biosimilars on the national market and t...

Full description

Bibliographic Details
Main Authors: Konstantin Tachkov, Zornitsa Mitkova, Vladimira Boyadzieva, Guenka Petrova
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Pharmaceuticals
Subjects:
biosimilars
pricing
reimbursement
utilization
Online Access:https://www.mdpi.com/1424-8247/14/1/64

Similar Items

Similar Items